Retired IPS officer Kiran Bedi has sought to intervene in a Delhi High Court case regarding the collapse of a hostel building in Satya Niketan, which resulted in seven deaths. The court acknowledged her experience despite opposition from the Centre, Delhi government, and MCD, who were given three days to respond to her plea. The High Court had previously ordered an inquiry into the September 6 collapse, highlighting concerns about housing safety and regulatory measures.
India has initiated anti-dumping investigations into imports of Glycine from China, following a complaint by Avid Organics, alleging material injury to domestic manufacturers. Concurrently, a separate anti-circumvention probe has begun concerning CPVC resin from China and South Korea, suspected of being routed through Malaysia, Japan, and Thailand to avoid existing duties.
Retired IPS officer Kiran Bedi on Thursday approached the Delhi high court seeking to be made a party in a matter concerning the hostel building collapse in Satya Niketan that left seven people dead, saying she wanted to bring forth "critical public domain disclosures" and the "nexus" in the operation of PG hostels.
Odisha-based Serendipity Space successfully demonstrated drug crystallisation processes on a satellite prototype in a near-space mission. This breakthrough aims to enable pharmaceutical manufacturing in low Earth orbit, leveraging microgravity to create superior drug crystal structures for enhanced solubility, stability, and effectiveness. The mission tested core technologies, including an autonomous pharmaceutical factory, and was inspired by advancements made on the International Space Station.
Tragedy struck two New Jersey families with Rutgers University graduates Navam Kaul and Malaika Chitre, both 24, hit by a subway train in Manhattan.
Researchers at IIT Madras have patented a chemical-free antibacterial surface that physically eliminates harmful bacteria, including "superbugs," without relying on antibiotics or disinfectants. This innovative technology uses specially engineered nanostructures to rupture bacterial cell walls, offering a sustainable solution to Antimicrobial Resistance (AMR) for biomedical and public health applications.
Pharma major Lupin is significantly increasing its focus on biosimilars, aiming for a turnover of nearly $500 million from this segment over the next five years, driven by new product launches and expanded presence in key global markets like the US, Europe, and Japan.
The Bombay High Court has strongly criticised the Maharashtra FDA for its "shoot first" approach, likening its drastic actions to using a sword to kill a mosquito. The court, hearing a petition from Cadila Pharmaceuticals, directed the FDA to grant companies a hearing before taking severe measures, warning of heavy costs for its arbitrary conduct.
Prime Minister Narendra Modi met Iranian President Masoud Pezeshkian at the SCO summit, advocating for dialogue and diplomacy to resolve the West Asia conflict and expressing India's desire to expand and diversify trade with Iran. Pezeshkian, in turn, urged India to leverage its contacts to promote peace.
Indian pharmaceutical companies are not rushing to relocate manufacturing to the United States despite former President Donald Trump's renewed threat of tariffs up to 200 per cent on imported generic drugs. Instead, they are leveraging existing US plants, contract manufacturers, and making selective investments in complex products while maintaining India as their primary production hub.
The political confidence required to place high-end Japanese aircraft and personnel on Indian soil is itself a data point.
It indicates a level of trust that would have been difficult to imagine when India-Japan defence ties were largely symbolic, explains Varun Arya.
Indian benchmark equity indices extended their losing streak for a fourth consecutive day, with the Sensex tumbling 417 points due to rising crude oil prices and a significant sell-off in IT stocks, impacting overall investor sentiment.
The benchmark BSE Sensex rebounded by 362 points, ending a four-day losing streak, driven by strong buying in metal, private banking, and oil and gas shares, while the broader NSE Nifty saw modest gains despite paring some advances in the closing session.
India has attracted foreign direct investment (FDI) worth approximately 4,896 crore across 29 projects since May, following the government's relaxation of norms under Press Note 2 of 2026. The revised rules permit investment without government approval from entities with up to 10 per cent non-controlling ownership by land-bordering countries.
Indian benchmark equity indices, Sensex and Nifty, rebounded in early trade after a three-day slide, driven by strong buying in blue-chip bank stocks and a firm trend in global markets, supported by easing US bond yields and record foreign-currency deposit inflows.
Newly listed companies Vedanta Aluminium Metal, SBI Funds Management and Manipal Health Enterprises have entered the Rs 1 trillion mcap list since March 2026.
Students are learning to combine technology with agriculture, healthcare, biotechnology, architecture and fashion, explains Mandeep Singh, assistant professor and deputy dean, Lovely Professional University.
For India, the goal is not simply to host another grand diplomatic gathering. It is to prove that a diverse coalition of emerging powers can still deliver.
External Affairs Minister S Jaishankar visited Kyiv, reiterating India's readiness to assist in ending the Ukraine-Russia war. He emphasised that solutions would not emerge from the battlefield and highlighted Prime Minister Modi's call for an end to the conflict. Discussions also covered humanitarian aid, the impact on commercial shipping, and bilateral trade, with Jaishankar inviting his Ukrainian counterpart to India for further talks.
The question for the next 20 years is not whether India can become a $5 trillion or $10 trillion economy. Those are attractive targets, but the real question is whether India can create enough productive jobs, educate its children properly, make its cities liveable, and give hundreds of millions of people a substantially better life, asserts Ramesh Menon.
Sun Pharmaceutical Industries reported a 27 per cent year-on-year increase in consolidated net profit to 2,894.7 crore for Q1FY27, with revenue growing 10 per cent to 15,299.8 crore, driven by strong performance in India and innovative medicines.
Bank credit to industry in India surged by 20 per cent year-on-year in July, significantly accelerating from the previous year, driven by strong expansion in sectors like engineering, gems and jewellery, and petroleum-related industries, according to the Reserve Bank of India (RBI). However, growth in gold loans, while still expanding, saw a sharp moderation.
US President Donald Trump announced steep tariffs on imported generic medicines, effective from August 2028, with the aim of boosting domestic pharmaceutical production. This policy, which includes a phased increase in tariffs up to 200 per cent, could significantly impact India, a major global supplier of generic drugs to the US market.
'The Chinese military cannot advance much in Ladakh, even if they want to.' 'Similarly, in Arunachal Pradesh, they can rename a village or two, intrude here or there, but cannot do much more realistically.'
If India does get $100 billion a year in FDI, it would be a game-changer in every possible way. FPIs would come rushing back, AI or no AI, points out Debashis Basu.
An 11-year-old rape survivor in Yamunanagar, Haryana, has given birth to a baby girl at the District Civil Hospital. Both the mother and baby are in stable condition. The minor's pregnancy was discovered in May, leading to the arrest of the accused under the POCSO Act. The family has consented to hand over the newborn to the Child Welfare Committee.
Russia remains India's biggest fertiliser supplier, with imports rising nearly 40 per cent in 2025.
rediffGURU Nayagam PP advises young aspirants how to pick the right course and career.
Indian benchmark indices Sensex and Nifty tumbled nearly 1 per cent for the third consecutive day, driven by a sharp spike in crude oil prices and significant selling in bank stocks, with Brent crude jumping to USD 95.27 per barrel.
Researchers at Delhi's Indraprastha Institute of Information Technology have developed 'MutAIverse', a generative AI platform designed to decode DNA damage and identify potential causes of cancer. Tested on head and neck cancer patients in Guwahati, the platform successfully traced exposure to smokeless tobacco as a contributing factor. This innovation aims to shift focus from just diagnosis to understanding causative factors, potentially aiding in prevention and protection.
'Think of the brain like a machine, and Alzheimer's is like rust.'
'Like a rusty machine breaks down, a rusty brain also breaks down. And when it breaks down, you have memory loss, cognitive issues and so on.'
Homegrown pharma major Cipla Ltd reported a 39 per cent decline in consolidated net profit to Rs 785.55 crore in the first quarter ended June 2026, primarily due to a dip in sales in the North American market and higher expenses.
A Parliamentary Standing Committee on Commerce has urged the Indian government to swiftly conclude the proposed India-US Bilateral Trade Agreement (BTA), while ensuring India's interests are protected, recommending complete exemption for key export products like generic medicines and smartphones from future US tariff increases.
Specialty chemicals maker Anupam Rasayan India Ltd has become the first company globally to commercialise Ethyl trifluoroacetate (ETFA) production using its proprietary continuous flow chemistry platform. This innovative technology offers significant advantages over traditional methods, and ETFA is a crucial component for pharmaceuticals, life sciences, and performance materials, with a global market estimated at USD 500-600 million.
Rockwell Automation's CEO Blake Moret highlights India as the centrepiece of the company's Asian growth strategy, detailing its four-decade presence, significant employee base, and support for the 'Make in India' initiative. The company sees major opportunities in pharmaceuticals, automotive, food and beverage, and consumer products, with AI playing a crucial role in simplifying industrial automation and boosting productivity for Indian manufacturers, including MSMEs.
Indian companies' overseas expansion plans are holding strong despite geopolitical tensions in West Asia, driven by structural factors like supply-chain diversification, free trade agreements, and market expansion, according to Ajay Sharma, managing director and head of banking at HSBC India.
Companies are investing heavily in complex injectables, respiratory therapies and biosimilars to improve margins and diversify portfolios.
'The market is currently neither cheap enough to be exciting about nor expensive enough to worry about.'
The remarkable rise of smallcaps reflects the emergence of a broad set of specialised businesses operating in industries where the sectoral tailwinds remain considerably stronger than macroeconomic headwinds, points out Debashis Basu.
BikeWo Green Tech and Kwik Flite Support have signed an initial pact to develop an integrated air cargo, aviation logistics, and multimodal freight platform. This collaboration aims to combine road mobility with aviation capabilities to serve various industries, focusing on high-value and time-sensitive logistics across India, including Tier-II and Tier-III cities.
